OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
6 hedge funds and large institutions have $226K invested in Oasmia Pharmaceutical AB in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$16K |
| 2 |
2
Bank of New York Mellon
New York
|
$12K |
Top Sellers
| 1 |
OMC
1
Old Mission Capital
Chicago,
Illinois
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $179K | 203,170 | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $17K | 19,000 | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $16K | 18,488 | +18,488 | New |
|
|
4
Bank of New York Mellon
New York
| $12K | 13,450 | +13,450 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $2K | 2,039 | -1,602 | -44% |
|
|
OMC
6
Old Mission Capital
Chicago,
Illinois
| – | – | -16,919 | Closed |
|
7
Morgan Stanley
New York
| $0 | 1 | +1 | New |
|